Article: SUDDEN END TO HORMONE REPLACEMENT STUDY THE DRUGS INCREASED THE RISK FOR BREAST CANCER, HEART DISEASE, STROKES AND BLOOD CLOTS.(FRONT)

Byline: Patricia Guthrie Atlanta Journal-Constitution

Researchers abruptly halted a major federal study of hormone replacement therapy -- used by tens of millions of American women -- because the drugs create what they consider an unacceptable risk for breast cancer, heart disease, strokes and blood clots.

The study found women taking a combination of estrogen and progestin are at increased risks that outweigh the benefits of the hormones, which were found to reduce the risks of colon cancer and hip fractures.

Findings from the study, called the Women's Health Initiative, had not been expected until 2008. But when evidence of the risks started ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!